EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.6.3.3 | Carcinoma |
19293182 |
A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
1 |
| 1.6.3.3 | Carcinoma |
21167810 |
XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 1.6.3.3 | Carcinoma in Situ |
19293182 |
A novel human AlkB homologue, ALKBH8, contributes to human bladder cancer progression. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
3
4
1 |
| 1.6.3.3 | Carcinoma, Squamous Cell |
21167810 |
XPC silencing in normal human keratinocytes triggers metabolic alterations through NOX-1 activation-mediated reactive oxygen species. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 1.6.3.3 | Cardiomyopathies |
30102640 |
Myocardial Redox Hormesis Protects the Heart of Female Mice in Sepsis. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 1.6.3.3 | Colonic Neoplasms |
23071493 |
TLR-4 signalling accelerates colon cancer cell adhesion via NF-?B mediated transcriptional up-regulation of Nox-1. |
unassigned |
0 |
| 1.6.3.3 | COVID-19 |
33791717 |
Transcriptome and Functions of Granulocytic Myeloid-Derived Suppressor Cells Determine their Association with Disease Severity of COVID-19. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 1.6.3.3 | COVID-19 |
34341659 |
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 1.6.3.3 | Dental Caries |
10656297 |
Streptococcus mutans H2O2-forming NADH oxidase is an alkyl hydroperoxide reductase protein. |
causal interaction
unassigned |
1
0 |
| 1.6.3.3 | Galactosemias |
23828587 |
Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
3
4
1
0 |
